Literature DB >> 19178851

[Visuospatial learning impairment in Parkinson Disease].

Iván Galtier1, Antonieta Nieto, José Barroso, Jesús Norelis Lorenzo.   

Abstract

Visuospatial learning impairment in Parkinson Disease. Despite the fact that different mnesic processes have been found to be impaired in Parkinson's disease, spatial learning is still an unstudied aspect. The aims of the present study were to evaluate visuospatial and verbal learning in nondemented patients with Parkinson's disease (PD) (N= 20), and to assess the influence of processing speed, attention, working memory, and visuospatial perception. Compared to controls (N= 20), PD patients had a poorer performance on Spatial Span, Judgment Line Orientation Test (JLOT), and 8/30 SRT. No differences were found between patients and controls in other functions assessed. Regression analysis showed that performance on Spatial Span and JOLT explains 58.2% of the variance of total spatial learning. Our results suggest an early impairment of spatial working memory and visuospatial perception in patients with PD. The visuospatial learning impairment may result from a primary deficit in these functions. These results suggest a global affectation of visuospatial processes, which may arise from dysfunction of the cortico-striatal circuits that include prefrontal and posterior parietal cortex.

Entities:  

Mesh:

Year:  2009        PMID: 19178851

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  4 in total

Review 1.  A Comprehensive Meta-analysis on Short-term and Working Memory Dysfunction in Parkinson's Disease.

Authors:  Ari Alex Ramos; Liana Machado
Journal:  Neuropsychol Rev       Date:  2021-02-01       Impact factor: 7.444

2.  Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Ronald D Chervin; Kirk A Frey; Nicolaas I Bohnen
Journal:  Ann Neurol       Date:  2012-04       Impact factor: 10.422

3.  Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.

Authors:  Sophie Fengler; Josef Kessler; Lars Timmermann; Alexandra Zapf; Saskia Elben; Lars Wojtecki; Oliver Tucha; Elke Kalbe
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

4.  Regional Metabolic Changes Influencing Three-Dimensional Perception in Parkinson's Disease.

Authors:  Yoonah Park; Kun-Woo Park; Chan-Nyoung Lee
Journal:  J Clin Neurol       Date:  2022-07       Impact factor: 2.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.